Logo

Millipore Reports Increase in Revenues, Net Income

Jul 21, 2004

NEW YORK, July 21 (GenomeWeb News) - Millipore announced today that its second-quarter revenues jumped 14 percent to $225 million, from $196 million in Q2 2003.

 

Revenues jumped in each of the company's three geographic areas. Revenues increased In the Americas by $13 million, in Europeby $12 million, and in the Asia/Pacific regions by $4 million, the company said.

 

R&D spending in the second quarter increased slightly to about $16 million, from $14 million in the same quarter last year. In addition, the company reported an increase in net income, to approximately $28.5 million, from about $22.3 million in the year-ago period.

 

Millipore, based in Billerica, Mass., said it had about $94 million in cash and cash equivalents as of June 30.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.